Follow


Submissions from 2016

PDF

Use of PKC-iota inhibitors for the treatment of breast cancer, Mildred E. Acevedo-Duncan, Diondra D. Hill, and David A. Ostrov

PDF

Method of treating ovarian cancer using a PKC inhibitor, Mildred E. Acevedo-Duncan, David Ostrov, Minjel Shah, Christopher Apostolatos, and Hercules Apostolatos

PDF

Joint physical layer security and PAPR mitigation in OFDM systems, Zekeriyya E. Ankarali and Huseyin Arslan

PDF

Prevention and Treatment of Alzheimer's Disease Through Electromagnetic Field Exposure, Gary W. Arendash, Chuanhai Cao, and Jun Tan

PDF

Cytotoxin compounds and methods of isolation, Bill J. Baker, Thushara Diyabalanage, James B. McClintock, and Charles D. Amsler

PDF

Ferromagnetic cell and tissue culture microcarriers, Jeanne L. Becker

PDF

Shunt catheter system, Joshua M. Beckman

PDF

Knot tying devices, David Andrew Bowman Jr. and Joel Anthony Jenkins

PDF

Effective treatment of esophageal adenocarcinoma using triciribine and related compounds, Jing Q. Cheng

PDF

Micro-RNA profiling in ovarian cancer, Jin Q. Cheng

PDF

Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof, Jin Q. Cheng and Said M. Sebti

PDF

Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof, Jin Q. Cheng and Said M. Sebti

PDF

Compositions including triciribine and methods of use thereof, Jin Q. Cheng and Said M. Sebti

PDF

Compositions including triciribine and one or more platinum compounds and methods of use thereof, Jin Q. Cheng and Said M. Sebti